144864-80-2

Upstream product

• 621-59-0 isovanillin 
• 144864-78-8 <3(2R),4R,5S>-3-<2-azido-2-(3-benzyloxy-4-methoxyphenyl)-1-oxoethyl>-4-methyl-5-phenyl-2-oxazolidinone 
• 159579-64-3 (2R)-2-Azido-2-<(3-(benzyloxy)-4-methoxy)phenyl>acetic acid 
• 144864-77-7 (4R,5S)-3-<2-(3-benzyloxy-4-methoxyphenyl)-1-oxoethyl>-4-methyl-5-phenyl-2-oxazolidinone 
• 144864-76-6 1-methylsulfinyl-1-methylthio-2-(3-benzyloxy-4-methoxyphenyl)ethylene 
• 100-39-0 benzyl bromide 
• 5487-33-2 O-benzylhomoisovanillic acid 
• 6346-05-0 3-benzyloxy-4-methoxybenzaldehyde 
• 178217-01-1 (R)-(3-Benzyloxy-4-methoxy-phenyl)-((S)-2-hydroxy-1-phenyl-ethylamino)-acetonitrile 
• 144864-79-9 methyl (2R)-azido-2-(3-benzyloxy-4-methoxyphenyl)acetate 

Downstream Products

• 178217-03-3 (R)-[(S)-2-Azido-2-(3,5-dimethoxy-phenyl)-acetylamino]-(3-benzyloxy-4-methoxy-phenyl)-acetic acid methyl ester 
• 178217-04-4 (R)-[(S)-2-Amino-2-(3,5-dimethoxy-phenyl)-acetylamino]-(3-hydroxy-4-methoxy-phenyl)-acetic acid methyl ester 
• 178217-07-7 (R)-[(S)-2-[(R)-2-tert-Butoxycarbonylamino-3-(4-fluoro-3-nitro-phenyl)-propionylamino]-2-(3,5-dimethoxy-phenyl)-acetylamino]-(3-hydroxy-4-methoxy-phenyl)-acetic acid methyl ester 
• 144864-71-1 (S)-(3-Benzyloxy-4-methoxy-phenyl)-((S)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionylamino)-acetic acid methyl ester 
• 144864-71-1 (R)-(3-Benzyloxy-4-methoxy-phenyl)-((S)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionylamino)-acetic acid methyl ester 
• 144864-71-1 (S)-(3-Benzyloxy-4-methoxy-phenyl)-((R)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionylamino)-acetic acid methyl ester 
• 144864-72-2 (R)-(3-Benzyloxy-4-methoxy-phenyl)-((R)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionylamino)-acetic acid methyl ester 

Relevant academic research and scientific papers

Synthetic studies towards glycopeptide antibiotics: Synthesis of the 16-membered cyclic tripeptide (DOEG ring) system of teicoplanin

The synthesis of the 16-membered cyclic DOEG ring system of teicoplanin, which forms the binding pocked for the carboxylate region of terminal D-Ala-D-Ala of the bacterial cell wall via macroetherification of linear tripeptide 20 is described.

Studies on ristocetin A. A synthesis of protected ristomycinic acid using organomanganese chemistry

Aryl ether formation by reaction of phenoxide nucleophiles with chloroarene-Mn(CO)3 cationic complexes, followed by reaction of the aryloxyarene-Mn(CO)3 complex with chiral glycine enolate equivalents, provides methodology for the synthesis of protected ristomycinic acid derivatives in a state of high optical purity.